期刊文献+

循环血microRNA在肝纤维化发生发展中的作用

Role of circulating microRNAs in development and progression of liver fibrosis
下载PDF
导出
摘要 MiroRNA(miRNA)可通过外泌体等载体分泌,游离于细胞之外,并可在循环血液中保持稳定状态。目前研究表明,循环血中miRNA的变化趋势与疾病的不同病理状态相关,提示循环血中miRNA可作为疾病潜在的诊断和治疗分子靶标。研究表明多种miRNA与肝纤维化的发生发展密切相关,概述了目前关于肝纤维化进程中循环血miRNA表达差异的研究,多种研究提示循环血miRNA可为肝纤维化的无创性早期诊断和治疗提供新的研究方向。 Recent studies have found that microRNAs( miRNAs) can be secreted via exosomes,stay outside the cells,and keep stable in circulating blood. Various studies have shown that the changes in circulating miRNAs are associated with different pathological states,suggesting that the circulating miRNAs can be used as potential molecular targets for the diagnosis and treament of diseases. Research has shown that miRNAs are closely associated with the development and progression of liver fibrosis. This article reviews the studies on the differences in the expression of circulating miRNAs in the course of liver fibrosis and points out that circulating microRNAs can provide a new research direction for early noninvasive diagnosis and treatment of liver fibrosis.
出处 《临床肝胆病杂志》 CAS 2016年第10期2001-2003,共3页 Journal of Clinical Hepatology
关键词 肝硬化 微RNAS 综述 liver cirrhosis microRNAs review
  • 相关文献

参考文献34

  • 1LAWRIE CH, GAL S, DUNLOP HM, et al. Detection of ele-vated levels of tumour - associated microRNAs in serum ofpatients with diffuse large B - cell lymphoma [ J ]. Br JHaematol, 2008, 141 (5) : 672 -675.
  • 2CARVALHO INSR, FREITAS RM, VARGAS FR. TranslatingmicroRNAs into biomarkers: What is new for pediatric canc-er? [J]. Med Oncol, 2016, 33(5) : 49.
  • 3LI A, YU J, KIM HY, et al. MicroRNA array analysis finds ele-vated serum miR -1290 accurately distinguishes patients withlow - stage pancreatic cancer from healthy and disease con-trols. [J]. Clin Cancer Res, 2013, 19(13): 3600 -3610.
  • 4KJERSEM JB, IKDAHL T, LINGJAERDE OC, et al. PlasmamicroRNAs predicting clinical outcome in metastatic colorec-tal cancer patients receiving first - line oxaliplatin - basedtreatment[J] . Mol Oncol, 2014, 8(1): 59 -67.
  • 5GALLO A, TANDON M, ALEVIZOS I,et al. The majority ofmicroRNAs detectable in serum and saliva is concentrated inexosomes[ J]. PLoS One, 2012, 7(3): e30679.
  • 6FUJITA Y, YOSHIOKA Y, OCHIYA T. Extracellular vesicle trans-fer of cancer pathogenic components[J]. Cancer Sci, 2016,107(4):385 -390.
  • 7STREMERSCH S, VANDENBROUCKE RE, van WONTERGHEME,et al. Comparing exosome - like vesicles with liposomes forthe functional cellular delivery of small RNAs[J]. J Control Re-lease, 2016, 232: 51 -61.
  • 8COENEN -STASS AM, MAGER I, WOOD MJ. ExtracellularmicroRNAs in membrane vesicles and non -vesicular carriers[J]. EXS,2015, 106: 31 -53.
  • 9ZHANG QQ, XU MY, QU Y, etal. Analysis of the differentialexpression of circulating microRNAs during the progressionof hepatic fibrosis in patients with chronic hepatitis B virus in-fection[J]. Mol Med Rep, 2015, 12(4) : 5647 -5654.
  • 10ARROYO JD, CHEVILLET JR, KROH EM, etal. Argonaute2complexes carry a population of circulating microRNAs inde-pendent of vesicles in human plasma[ J]. Proc Natl Acad SciUSA, 2011,108(12) : 5003 -5008.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部